Imran Khan

Title: Imran Khan: Innovator in Cell Targeting Therapeutics

Introduction

Imran Khan is a notable inventor based in New Delhi, India. He has made significant contributions to the field of cell-specific therapeutic modalities. His innovative work focuses on utilizing the placental-like alkaline phosphatase (PLAP) promoter for targeted cell therapy.

Latest Patents

Imran Khan holds a patent for a groundbreaking invention titled "Placental like alkaline phosphatase (PLAP) promoter mediated cell targeting." This invention relates to a cell-specific therapeutic modality that employs a region of the PLAP promoter. It further explores the specific expression of therapeutically useful PLAP sequences for the transcriptional activation of this gene. The invention also discusses the PLAP region, which can be used alone or in combination with enhancer sequences to augment cell or tumor-specific gene expression. He has 1 patent to his name.

Career Highlights

Throughout his career, Imran Khan has worked with prestigious institutions such as the National Brain Research Centre and the All India Institute of Medical Sciences. His work in these organizations has contributed to advancements in medical research and therapeutic applications.

Collaborations

Imran has collaborated with notable coworkers, including Subrata Sinha and Mohammad Khalid Zakaria. Their collective efforts have furthered the research and development of innovative therapeutic solutions.

Conclusion

Imran Khan's contributions to the field of cell targeting therapeutics highlight his innovative spirit and dedication to advancing medical science. His work continues to inspire future research in targeted therapies.